Prophylactic cranial irradiation in lung cancer

Cancer Treatment Reviews

Volumn 37, Issue 4, 2011, Pages 261-265

  Paumier, A ^a   Cuenca, X ^a   Le Pechoux C ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Combined modality treatment; Lung cancer; Non small cell lung cancer; Prophylactic cranial irradiation; Small cell lung cancer

Indexed keywords

BRAIN METASTASIS; CANCER SURVIVAL; HUMAN; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; META ANALYSIS (TOPIC); OVERALL SURVIVAL; PROPHYLAXIS; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; SKULL IRRADIATION; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; LUNG NEOPLASMS;

EID: 79953090908     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2010.08.009     Document Type: Review

References (51)

1. Hochstenbag M.M., Twijnstra A., Wilmink J.T., Wouters E.F., Velde G.P. Asymptomatic brain metastases (BM) in small cell lung cancer (SCLC): MR-imaging is useful at initial diagnosis. J Neurooncol 2000, 48:243-248.
2. Arriagada R., Le Chevalier T., Borie F., et al. Prophylactic cranial irradiation for patients with small cell lung cancer in complete remission. J Natl Cancer Inst 1995, 87:183-190.
3. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. N Engl J Med 1999, 341:476-484.
4. Patel S., Macdonald O.K., Suntharalingam M. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer. Cancer 2009, 115:842-850.
5. Le Pechoux C., Dunant A., Senan S., et al. Standard-dose versus higher-dose prophylactic cranial irradiation (PCI) in patients with limited-stage small-cell lung cancer in complete remission after chemotherapy and thoracic radiotherapy (PCI 99-01, EORTC 22003-08004, RTOG 0212, and IFCT 99-01): a randomized clinical trial. Lancet Oncol 2009, 10:467-474.
6. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 2007, 357:664-672.
7. Albain K.S., Rusch V.W., Crowley J.J., et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB nons mallcell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol 1995, 13:1880-1892.
8. Andre F., Grunenwald D., Pujol J.L., et al. Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapy: should prophylactic cranial irradiation be reconsidered?. Cancer 2001, 91:2394-2400.
9. Gaspar L.E., Chansky K., Albain K.S., et al. Time from treatment to subsequent diagnosis of brain metastases in stage III nonsmall-cell lung cancer: a retrospective review by the Southwest Oncology Group. J Clin Oncol 2005, 23:2955-2961.
10. Strauss G.M., Herndon J.E., Sherman D.D., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA nonsmall-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10:1237-1244.
11. Cox J.D., Yesner R.A. Adenocarcinoma of the lung: recent results from the Veterans Administration Lung Group. Am Rev Respir Dis 1979, 120:1025-1029.
12. Carolana H., Suna A.Y., Bezjak A., et al. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?. Lung Cancer 2005, 49:109-115.
13. Robnett T.J., Machtay M., Stevenson J.P., Algazy K.M., Hahn S.M. Factors affecting the risk of brain metastases after definitive chemoradiation for locally-advanced non-small-cell lung carcinoma. J Clin Oncol 2001, 19:1344-1349.
14. Yokoi K., Kamiya N., Matsuguma H., et al. Detection of brain metastasis in potentially operable non-small cell lung cancer: a comparison of CT and MRI. Chest 1999, 115:714-719.
15. Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data. Lancet 2010, 375:1267-1277. NSCLC Meta-analyses Collaborative Group.
16. Auperin A., Le Péchoux C., Rolland E., et al. Concomitant versus sequential radiotherapy and chemotherapy in locally advanced non-small cell lung cancer: a meta-analysis using individual patient data from randomized clinical trials. J Clin Oncol 2010, 28:2181-2190. on behalf of the NSCLC Collaborative Group.
17. Line D.H., Deeley T.J. The necropsy findings in carcinoma of the bronchus. Br J Dis Chest 1971, 65:238-242.
18. Cox J.D., Scott C.B., Byhardt R.W., et al. Addition of chemotherapy to radiation therapy alters failure patterns by cell type within non-small cell carcinoma of lung (NSCCL): analysis of radiation therapy oncology group (RTOG) trials. Int J Radiat Oncol Biol Phys 1999, 43:505-509.
19. Ceresoli G.L., Reni M., Chiesa G., et al. Brain metastases in locally advanced non-small cell lung carcinoma after multimodality treatment: risk factors analysis. Cancer 2002, 95:605-612.
20. Strauss G.M., Herndon J.E., Sherman D.D., et al. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. J Clin Oncol 1992, 10:1237-1244.
21. Bajard A., Westeel V., Dubiez A., et al. Multivariate analysis of factors predictive of brain metastases in localized non-small cell lung carcinoma. Lung Cancer 2004, 45:317-323.
22. Lee Y.J., Choi H.J., Kim S.K., et al. Frequent central nervous system failure after clinical benefit with epidermal growth factor receptor tyrosine kinase inhibitors in Korean patients with nonsmall-cell lung cancer. Cancer 2010, 116:1336-1343.
23. Figlin R.A., Piantadosi S., Feld R. Intracranial recurrence of carcinoma after complete surgical resection of stage I, II, and III non-small cell lung cancer. N Engl J Med 1988, 318:1300-1305.
24. Mamon H.J., Yeap B.Y., Jänne P.A., et al. High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005, 23:1530-1537.
25. Rusch V.W., Giroux D.J., Kraut M.J., et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007, 25:313-318.
26. Komaki R., Scott C.B., Byhardt R., et al. Failure patterns by prognostic group determined by recursive partitioning analysis (RPA) of 1547 patients on four radiation therapy oncology group (RTOG) studies in inoperable nonsmall-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1998, 1(42):263-267.
27. Langer C.J., Mehta M.P. Current management of brain metastases, with a focus on systemic options. J Clin Oncol 2005, 23:6207-6219.
28. Nieder C., Bremnes R., Andratschke N.H. Prognostic scores in patients with brain metastases from non-small cell lung cancer. J Thorac Oncol 2009, 4:1337-1341.
29. Kepka L., Cieslak E., Bujko K., Fijuth J., Wierzchowski M. Results of the whole-brain radiotherapy for patients with brain metastases from lung cancer: the RTOG RPA intra-classes analysis. Acta Oncol 2005, 44:389-398.
30. Li B., Yu J., Suntharalingam M., et al. Comparison of three treatment options for single brain metastasis from lung cancer. Int J Cancer 2000, 90:37-45.
31. Mehta M.P., Paleologos N.A., Mikkelsen T., et al. The role of chemotherapy in the management of newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol 2010, 96:71-83.
32. Ceresoli G.L., Cappuzzo F., Gregorc V., et al. Gefitinib in patients with brain metastases from non small-cell lung cancer: a prospective trial. Ann Oncol 2004, 15:1042-1047.
33. Katayama T., Shimizu J., Suda K. Efficacy of erlotinib for brain metastases in patients with lung adenocarcinoma who showed initial good response to gefitinib. J Thorac Oncol 2009, 4:1-4.
34. Cox J.D., Stanley K., Petrovich Z., Paig C., Yesner R. Cranial irradiation in cancer of the lung of all cell types. JAMA 1981, 245:469-472.
35. Umsawasdi T., Valdivieso M., Chen T.T., et al. Role of elective brain irradiation during combined chemoradiotherapy for limited disease non-small cell lung cancer. J Neurooncol 1984, 2:253-259.
36. Russell A.H., Pajak T.E., Selim H.M., et al. Prophylactic cranial irradiation for lung cancer patients at high risk for development of cerebral metastasis: results of a prospective randomized trial conducted by the Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1991, 21:637-643.
37. Miller T.P., Crowley J.J., Mira J., et al. A randomized trial of chemotherapy and radiotherapy for stage III non-small cell lung cancer. Cancer Ther 1998, 4:229-236.
38. Gore E.M., Bae K., Wong S., et al. A phase III comparison of prophylactic cranial irradiation versus observation in patients with locally advanced nonsmall cell lung cancer: initial analysis of Radiation Therapy Oncology Group 0214. J Clin Oncol 2009, 27(Suppl.). [abstract #7506].
39. Pottgen C., Eberhardt W., Grannass A., et al. Prophylactic cranial irradiation in operable stage IIIA non-small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial. J Clin Oncol 2007, 25:4987-4992.
40. Cull A., Gregor A., Hopwood P., et al. Neurological and cognitive impairment in long-term survivors of small cell lung cancer. Eur J Cancer 1994, 30A:1067-1074.
41. Komaki R., Meyers C.A., Shin D.M., et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 1995, 33:179-182.
42. Grosshans D.R., Meyers C.A., Allen P.K., Davenport S.D., Komaki R. Neurocognitive function in patients with small cell lung cancer. Effect of prophylactic cranial irradiation. Cancer 2008, 112:589-595.
43. Van Oosterhout A.G., Ganzevles P.G., Wilmink J.T., De Geus B.W., Van Vonderen R.G., Twijnstra A. Sequelae in long-term survivors of small cell lung cancer. Int J Radiat Oncol Biol Phys 1996, 34:1037-1044.
44. Ahles T.A., Silberfarb P.M., Herndon J., et al. Psychologic and neuropsychologic functioning of patients with limited small-cell lung cancer treated with chemotherapy and radiation therapy with or without warfarin: a study by the Cancer and Leukemia Group B. J Clin Oncol 1998, 16:1954-1960.
45. Gregor A., Cull A., Stephens R.J., et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 1997, 33:1752-1758.
46. Le Pechoux C., Laplanche A., Faivre-Finn C., et al. Neuro-cognitive follow-up among patients with limited small cell cancer (SCLC) treated with two different doses of prophylactic cranial irradiation (PCI) according to the intergroup phase III trial (PCI99-01, IFCT 99-01, EORTC 22003-08004, RTOG 0212). J Thorac Oncol 2009, 4:S393.
47. Slotman B.J., Mauer M.E., Bottomley A., et al. Prophylactic cranial irradiation in extensive disease small-cell lung cancer: short-term health-related quality of life and patient reported symptoms: results of an international Phase III randomized controlled trial by the EORTC Radiation Oncology and Lung Cancer Groups. J Clin Oncol 2009, 27:78-84.
48. Orgogozo J.M., Rigaud A.S., Stoffler A., Mobius H.J., Forette F. Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke 2002, 33:1834-1839.
49. Gutiérrez A.N., Westerly D.C., Tomé W.A., et al. Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study. Int J Radiat Oncol Biol Phys 2007, 69:589-597.
50. Lee J.J., Bekele B.N., Zhou X., Cantor S.B., Komaki R., Lee J.S. Decision analysis for prophylactic cranial irradiation for patients with small-cell lung cancer. J Clin Oncol 2006, 24:3597-3603.
51. Wolfson A.H., Bae K., Komaki R., et al. Secondary endpoints of a phase ii randomized trial (RTOG 0212): impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited disease small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009, 75(Suppl. 3).